Board members - Its time to buy or go, page-75

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 75 Last

Share
Profile

Follow
AlCp

27,638 Posts.

1787

11/02/21

18:21

Post #: 50908505
Share

Originally posted by pilko3 ↑

it reinforces the real need to get rid of this team...TK out and several of the rest of them. I know TK is very bullish in the Medgate prospects but hey is he under the pump now or what? He should be doing a job, not fit for leadership,,,Sleepcheck advert/video showed what lack of marketing nouse they actuall have in there. Tragic to sit here and wait for some direction from Medgate etc etc. You would think TK would fall on his sword and move away to the areas he is good at...it doesn't appear to be a way out here unless Medgate becomes a gateway to an upward thrust at last. In defence Covid has smashed a lot of ResApdx trials and performance results from big hospitals and institutions as they had a monster pandemic on their (still have) hands. Doesn't do us any good. Nothing much does...this team are acting in an unkind and irresponsible manner towards us shareholders and have mae statements that were apparently without foundation and that led us to invest in RAP...also had us believing that things were turning around...between the Covid issue it could be just a matter of really bad timing on the company's behalf. We are damned either way...dichotomy from hell presenting itself to us over the last 6 months and no right way to go. Dismayed but not done for.

Expand

I always thought revenue from ED will be the last revenue stream for ResAppDx and take at least a year to generate anyway but I thought there would be "noise" from Europe telehealth provider because ResAppDx is well suited for COVID-19 which is running rampant in Europe.

RAP Price at posting: 6.7¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Making money: How many microcaps should be in an investor's portfolio?

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

'We're looking': Nickel-rich Indonesia sounds graphite warning to Aus producers

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

What each US election outcome would mean for Australian companies & investors

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers